A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma (CONNECT1)
CONNected Electronic Inhalers Asthma Control Trial 1 (CONNECT 1), a 12-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison, Feasibility Study to Evaluate the Effectiveness of the Albuterol eMDPI Digital System, to Optimize Outcomes in Patients at Least 13 Years of Age or Older With Asthma
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Listed as NCT03890666, this PHASE4 trial focuses on Asthma and remains completed. Sponsored by Teva Branded Pharmaceutical Products R&D, Inc., it has been updated 23 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
23 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Nov 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Sep 2022 — Nov 2022 [monthly]
Completed PHASE4
▶ Show 18 earlier versions
-
May 2022 — Sep 2022 [monthly]
Completed PHASE4
-
Apr 2022 — May 2022 [monthly]
Completed PHASE4
-
Mar 2022 — Apr 2022 [monthly]
Completed PHASE4
-
Feb 2022 — Mar 2022 [monthly]
Completed PHASE4
-
Dec 2021 — Feb 2022 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE4
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE4
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE4
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE4
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2019 — May 2020 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2019 — Jul 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Teva Branded Pharmaceutical Products R&D, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .